AU Patent

AU2003286258B2 — Composition and method for treating inflammatory diseases using protease inhibitors

Assigned to Arriva Prometic Inc · Expires 2006-12-21 · 19y expired

What this patent protects

Compositions containing a protease inhibitor and methods of use and production are described. The compositions contain an effective amount of a protease inhibitor in a carrier or diluent and are used for the treatment of inflammatory or hyperproliferic mucocutaneous disorders. Th…

USPTO Abstract

Compositions containing a protease inhibitor and methods of use and production are described. The compositions contain an effective amount of a protease inhibitor in a carrier or diluent and are used for the treatment of inflammatory or hyperproliferic mucocutaneous disorders. The carrier or diluent is preferably a gelling agent, and the composition is a topical gel formulation containing alpha 1 -antitrypsin in an aqueous liquid or viscous gel formulation.

Drugs covered by this patent

Patent Metadata

Patent number
AU2003286258B2
Jurisdiction
AU
Classification
—
Expires
2006-12-21
Drug substance claim
No
Drug product claim
No
Assignee
Arriva Prometic Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.